Providers should always review the most current FDA prescribing information for approved uses and safety guidance
Although OA pathogenesis is exceedingly complex, recent studies underscore the multifactorial nature of the disease, involving mechanical overload, inflammatory responses, metabolic abnormalities, and cell death ( Cartilage deterioration and subchondral bone remodeling are hallmarks of OA
The Core Benefits of Microdosing Liver and Cardiovascular Protection A 72-week trial found 40% of patients achieved resolution of fatty liver disease without worsening fibrosis. In animal models, GLP-1s suppress fat production in the liver and reduce inflammation. Tirzepatide at low doses showed particularly strong cardiovascular benefits, with meaningful improvements across multiple lipid markers linked to heart disease risk. Cholesterol storage forms increased far less with tirzepatide, and harmful lipids like ceramides showed minimal increase compared to placebo
This can lead to more significant results compared to single-agonist approaches
Supports the functioning of the nervous system Improves the myelination of nerve fibers Reduces neurological manifestations of hypovitaminosis (numbness, weakness, impaired coordination) 3
It works by signaling your pancreas to release insulin after meals, slowing digestion, and helping you feel fuller longerultimately controlling appetite and blood sugar more effectively
